299 related articles for article (PubMed ID: 34132342)
1. Vesicular drug delivery for the treatment of topical disorders: current and future perspectives.
Witika BA; Mweetwa LL; Tshiamo KO; Edler K; Matafwali SK; Ntemi PV; Chikukwa MTR; Makoni PA
J Pharm Pharmacol; 2021 Oct; 73(11):1427-1441. PubMed ID: 34132342
[TBL] [Abstract][Full Text] [Related]
2. Vesicles: a recently developed novel carrier for enhanced topical drug delivery.
Akhtar N
Curr Drug Deliv; 2014; 11(1):87-97. PubMed ID: 24533724
[TBL] [Abstract][Full Text] [Related]
3. Vesicular carriers for dermal drug delivery.
Sinico C; Fadda AM
Expert Opin Drug Deliv; 2009 Aug; 6(8):813-25. PubMed ID: 19569979
[TBL] [Abstract][Full Text] [Related]
4. Recent Advances in Lipid-Based Vesicles and Particulate Carriers for Topical and Transdermal Application.
Jain S; Patel N; Shah MK; Khatri P; Vora N
J Pharm Sci; 2017 Feb; 106(2):423-445. PubMed ID: 27865609
[TBL] [Abstract][Full Text] [Related]
5. Lipid vesicles: A versatile drug delivery platform for dermal and transdermal applications.
Chacko IA; Ghate VM; Dsouza L; Lewis SA
Colloids Surf B Biointerfaces; 2020 Nov; 195():111262. PubMed ID: 32736123
[TBL] [Abstract][Full Text] [Related]
6. Combinations of nanovesicles and physical methods for enhanced transdermal delivery of a model hydrophilic drug.
Zorec B; Zupančič Š; Kristl J; Pavšelj N
Eur J Pharm Biopharm; 2018 Jun; 127():387-397. PubMed ID: 29581043
[TBL] [Abstract][Full Text] [Related]
7. Liposomes and niosomes as topical drug delivery systems.
Choi MJ; Maibach HI
Skin Pharmacol Physiol; 2005; 18(5):209-19. PubMed ID: 16015019
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in non-ionic surfactant vesicles (niosomes): Fabrication, characterization, pharmaceutical and cosmetic applications.
Chen S; Hanning S; Falconer J; Locke M; Wen J
Eur J Pharm Biopharm; 2019 Nov; 144():18-39. PubMed ID: 31446046
[TBL] [Abstract][Full Text] [Related]
9. Novel elastic membrane vesicles (EMVs) and ethosomes-mediated effective topical delivery of aceclofenac: a new therapeutic approach for pain and inflammation.
Sharma G; Goyal H; Thakur K; Raza K; Katare OP
Drug Deliv; 2016 Oct; 23(8):3135-3145. PubMed ID: 26960815
[TBL] [Abstract][Full Text] [Related]
10. Ethosomes as dermal/transdermal drug delivery systems: applications, preparation and characterization.
Jafari A; Daneshamouz S; Ghasemiyeh P; Mohammadi-Samani S
J Liposome Res; 2023 Mar; 33(1):34-52. PubMed ID: 35695714
[TBL] [Abstract][Full Text] [Related]
11. Progress in novel ultradeformable vesicular drug carrier in the topical and transdermal treatment of psoriasis.
Nayak N; Somanna P; Patil AB; Radhakrishnan A
Ther Deliv; 2020 Dec; 11(12):807-819. PubMed ID: 33267650
[TBL] [Abstract][Full Text] [Related]
12. Ethosomes as Vesicles for Effective Transdermal Delivery: From Bench to Clinical Implementation.
Akhtar N; Varma A; Pathak K
Curr Clin Pharmacol; 2016; 11(3):168-190. PubMed ID: 27526697
[TBL] [Abstract][Full Text] [Related]
13. Ethosomes and Transfersomes: Principles, Perspectives and Practices.
Garg V; Singh H; Bimbrawh S; Singh SK; Gulati M; Vaidya Y; Kaur P
Curr Drug Deliv; 2017; 14(5):613-633. PubMed ID: 27199229
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo trans-epidermal water loss evaluation following topical drug delivery systems application for pharmaceutical analysis.
Cristiano MC; Froiio F; Mancuso A; Iannone M; Fresta M; Fiorito S; Celia C; Paolino D
J Pharm Biomed Anal; 2020 Jul; 186():113295. PubMed ID: 32361608
[TBL] [Abstract][Full Text] [Related]
15. Vesicular system: Versatile carrier for transdermal delivery of bioactives.
Singh D; Pradhan M; Nag M; Singh MR
Artif Cells Nanomed Biotechnol; 2015; 43(4):282-90. PubMed ID: 24564350
[TBL] [Abstract][Full Text] [Related]
16. Exploring Applications of Flexible Vesicular Systems as Transdermal Drug Delivery.
Kaur P; Verma S; Tomar B; Vyas M; Kakoty V; Saha P; Chandran SK
Curr Drug Deliv; 2024; 21(8):1062-1072. PubMed ID: 37649297
[TBL] [Abstract][Full Text] [Related]
17. Skin penetration and deposition of carboxyfluorescein and temoporfin from different lipid vesicular systems: In vitro study with finite and infinite dosage application.
Chen M; Liu X; Fahr A
Int J Pharm; 2011 Apr; 408(1-2):223-34. PubMed ID: 21316430
[TBL] [Abstract][Full Text] [Related]
18. Elastic liposomes as novel carriers: recent advances in drug delivery.
Hussain A; Singh S; Sharma D; Webster TJ; Shafaat K; Faruk A
Int J Nanomedicine; 2017; 12():5087-5108. PubMed ID: 28761343
[TBL] [Abstract][Full Text] [Related]
19. Niosomes as a propitious carrier for topical drug delivery.
Hamishehkar H; Rahimpour Y; Kouhsoltani M
Expert Opin Drug Deliv; 2013 Feb; 10(2):261-72. PubMed ID: 23252629
[TBL] [Abstract][Full Text] [Related]
20. Vesicular systems for delivering conventional small organic molecules and larger macromolecules to and through human skin.
El Maghraby GM; Williams AC
Expert Opin Drug Deliv; 2009 Feb; 6(2):149-63. PubMed ID: 19239387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]